A series of actions by President Donald Trump's administration have provoked profound anxiety among academic labs that ...

In a surprise move Thursday, Neumora remade its executive team and brought back its former CEO, following last month's ...

Agios' Pyrukynd met primary endpoint in Phase 3 study for children with PK deficiency who don't need regular transfusions, ...

Knownwell expands with 6 new Chicago locations, adding to existing Boston and Dallas clinics. CEO reports 78% virtual visits.

Sanofi faces $250M charge after E. coli vaccine developed with J&J fails Phase 3 trial; study ends early due to insufficient ...

The Senate on Thursday confirmed Robert F. Kennedy Jr. as secretary of Health and Human Services, putting a longtime ...

Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio has ended in disappointment after a deal announced in November fell through.